Consensus Evolus, Inc.

Equities

EOLS

US30052C1071

Market Closed - Nasdaq 04:00:00 2024-04-23 pm EDT 5-day change 1st Jan Change
11.7 USD -0.17% Intraday chart for Evolus, Inc. -2.90% +11.11%

Evolution of the average Target Price on Evolus, Inc.

Price target over the last 5 years

History of analyst recommendation changes

2b6629c.Rjt2GuHXlQw8NRE0gujWfmxNKAt9CtXdPvtU2BpGUGA.cVAvUbOV-Upjd3hs6tqzExt7G2EOboXqSboWtFFyAQ9wfxtv1OHMa1lYKQ~d8aac72d0dec42d015427cb2e5ce46ec
Evolus Insider Sold Shares Worth $1,344,604, According to a Recent SEC Filing MT
Mizuho Securities Adjusts Evolus Price Target to $23 From $20, Maintains Buy Rating MT
Barclays Upgrades Evolus to Overweight From Equalweight, Raises Price Target to $16 From $10 MT
HC Wainwright Adjusts Price Target on Evolus to $27 From $16, Maintains Buy Rating MT
Mizuho Securities Adjusts Evolus Price Target to $20 From $17, Maintains Buy Rating MT
Truist Securities Adjusts Price Target on Evolus to $18 From $14, Maintains Buy Rating MT
HC Wainwright Adjusts Price Target on Evolus to $16 From $15, Maintains Buy Rating MT
Mizuho Securities Adjusts Evolus' Price Target to $17 From $15, Keeps Buy Rating MT
Needham & Co Initiates Coverage on Evolus With Buy Rating, $18 Price Target MT
Barclays Upgrades Evolus to Equalweight From Underweight, Adjusts Price Target to $10 From $8 MT
Truist Securities Upgrades Evolus to Buy From Hold; Price Target is $11 MT
HC Wainwright Adjusts Evolus' Price Target to $15 From $22, Keeps Buy Rating MT
EVOLUS : Barclays Adjusts Evolus' Price Target to $7 From $8, Maintains Underweight Rating MT
EVOLUS : Mizuho Securities Upgrades Evolus to Buy From Neutral; Price Target is $15 MT
EVOLUS : HC Wainwright Adjusts Evolus' Price Target to $22 From $20, Maintains Buy Rating MT
EVOLUS : Mizuho Adjusts Evolus' Price Target to $15 From $9, Maintains Neutral Rating MT
EVOLUS : HC Wainwright Adjusts Evolus' Price Target to $20 From $18, Maintains Buy Rating MT
EVOLUS : Truist Securities Downgrades Evolus to Hold From Buy, Adjusts Price Target to $12 From $6 MT
EVOLUS : Barclays Adjusts Evolus' Price Target to $8 From $4, Reiterates Underweight Rating MT
EVOLUS : Mizuho Adjusts Evolus' Price Target to $9 From $5, Maintains Neutral Rating MT
EVOLUS : Cantor Fitzgerald Adjusts Evolus' Price Target to $20 From $11, Maintains Overweight Rating MT
EVOLUS : HC Wainwright Adjusts Evolus' Price Target to $18 From $6, Maintains Buy Rating MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
8
Last Close Price
11.7 USD
Average target price
22.29 USD
Spread / Average Target
+90.48%
High Price Target
27 USD
Spread / Highest target
+130.77%
Low Price Target
16 USD
Spread / Lowest Target
+36.75%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Evolus, Inc.

Mizuho Securities
Barclays
HC Wainwright
Truist Securities
Needham & Co.
Trading Rating
Investor Rating
ESG Refinitiv
D+
More Ratings
  1. Stock Market
  2. Equities
  3. EOLS Stock
  4. Consensus Evolus, Inc.